Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law Blog
DECEMBER 4, 2023
12, 2012). “[W]hen the circumstances surrounding the presentation of a prescription would give rise to suspicion in a ‘reasonable professional,’ there is a duty to question the prescription.” The Zarzamora decision identifies the following as prescribing red flags at issue in the case: 1. Holiday CVS, L.L.C. d/b/a CVS/Pharmacy, Nos.
139 
Let's personalize your content